Automatic Adaptive System Dialysis (AASD)

Status:

COMPLETED

Automatic Adaptive System Dialysis (AASD)

Lead Sponsor:

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Conditions:

Dialysis Intolerance

Eligibility:

All Genders

18+ years

Phase:

Brief Summary

AASD is a new dialysis technique based on the use of a mathematical model of intradialytic solutes and fluid kinetic, for the automatic elaboration of dialysate sodium and ultrafiltration rate profile...

Eligibility Criteria

Inclusion

Patients in HD/HDF (bicarbonate dialysis/hemodiafiltration) for at least 6 months
aged more than 18 years
on chronic thrice-weekly HD
symptomatic hypotension during at least 30% of dialysis sessions on basal treatment in the last month before admission or/and 1 hypotension /week
disequilibrium symptoms (cramps, headache, nausea, vomiting, hypotensive events) in at least 30% of dialysis sessions on basal treatment
dialysis session time: 4 hours (as much as possible)
Signed inform consent form
Patients having no vascular access related problems (bi-ponction, blood flow rate 300ml/min)

Exclusion

Patients in a pregnant state
Patients whose life expectancy is less than study period
Patients with progressive acute pathology (neoplasia…)
Patients included in an other protocol
Psychiatric patients or patients unable to consent or unable to follow the study

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01241994

Last Update

March 18 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)